Bahrain approves Pfizer/BioNTech COVID-19 vaccine use


By ELydf

MANAMA, Dec. 4 (Xinhua) -- Bahrain's health regulator on Friday announced the authorization of emergency use of the Pfizer/BioNTech COVID-19 vaccine.

"Bahrain has approved the emergency use of Pfizer/BioNTech COVID-19 vaccine that will be used for high risk groups," said the National Health Regulatory Authority (NHRA).

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

Russian Baltic port resumes crude loading after attacks, Bloomberg News reports
"The Super Mario Galaxy Movie" dominates North American box office in opening weekend
Russia discovers 276 solid mineral deposits in 2025: Putin
Interview: FAO chief economist warns of deepening global food risks amid Mideast tensions
OPEC+ to ramp up oil output in May amid global energy crisis
CSL Roundup: Shenhua secures comeback win, Chongqing continues unbeaten run
Bangladesh launches emergency vaccination campaign as measles outbreak spreads
Keiko Fujimori leads Peru's presidential polls a week before election
British royals gather for Easter service, with Andrew and his family absent
Trump says deal with Iran possible by Monday, Fox News reports

Others Also Read